荣泰健康
(603579)
| 流通市值：31.85亿 | | | 总市值：31.85亿 |
| 流通股本：1.39亿 | | | 总股本：1.39亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 400,613,890.42 | 1,855,029,390.81 | 1,298,074,815.73 | 889,901,502.72 |
| 营业收入 | 400,613,890.42 | 1,855,029,390.81 | 1,298,074,815.73 | 889,901,502.72 |
| 二、营业总成本 | 331,559,198.75 | 1,641,615,183.82 | 1,146,125,766.88 | 779,575,287.11 |
| 营业成本 | 256,891,135.34 | 1,283,241,376.66 | 884,597,773.7 | 610,899,068.61 |
| 税金及附加 | 2,748,306.17 | 10,094,878.33 | 6,749,436.07 | 4,089,111.07 |
| 销售费用 | 39,277,080.03 | 204,444,174.34 | 151,541,529.33 | 105,942,051.69 |
| 管理费用 | 20,521,223.62 | 78,547,495.6 | 56,366,402.79 | 36,592,695.82 |
| 研发费用 | 20,142,315.83 | 80,176,150.48 | 59,424,399.03 | 37,267,618.96 |
| 财务费用 | -8,020,862.24 | -14,888,891.59 | -12,553,774.04 | -15,215,259.04 |
| 其中:利息费用 | 742,926.04 | 27,407,578.53 | 24,778,414.21 | 17,565,466.97 |
| 其中:利息收入 | 6,936,784.12 | 34,843,493.34 | 26,525,143.72 | 18,800,372.49 |
| 加:公允价值变动收益 | 640,110.25 | -16,218,630.62 | -15,421,768.88 | -12,331,071.86 |
| 加:投资收益 | -1,932,491.35 | 29,264,055.28 | 24,529,034.4 | 14,425,979.58 |
| 资产处置收益 | -13,508.33 | -951,752.36 | -729,990.68 | -133,233.7 |
| 资产减值损失(新) | -324,284.6 | -6,615,134.13 | -3,293,954.99 | -1,101,975.7 |
| 信用减值损失(新) | 566,690.13 | -139,155.67 | 2,073,749.05 | 89,979.27 |
| 其他收益 | 1,262,583.94 | 17,201,548.67 | 9,674,803.93 | 7,886,123.25 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 69,253,791.71 | 235,955,138.16 | 168,780,921.68 | 119,162,016.45 |
| 加:营业外收入 | 27,547.24 | 955,477.57 | 3,852,592.48 | 1,120,175.64 |
| 减:营业外支出 | 17,647.26 | 6,718,952.81 | 1,611,972.87 | 1,477,071.2 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 69,263,691.69 | 230,191,662.92 | 171,021,541.29 | 118,805,120.89 |
| 减:所得税费用 | 6,416,345.43 | 26,859,754.72 | 18,543,914.76 | 13,451,902.37 |
| 六、净利润 | 62,847,346.26 | 203,331,908.2 | 152,477,626.53 | 105,353,218.52 |
| 持续经营净利润 | 62,847,346.26 | 203,331,908.2 | 152,477,626.53 | 105,353,218.52 |
| 归属于母公司股东的净利润 | 62,741,790.01 | 202,706,851.03 | 151,734,129.17 | 104,917,854.04 |
| 少数股东损益 | 105,556.25 | 625,057.17 | 743,497.36 | 435,364.48 |
| (一)基本每股收益 | 0.47 | 1.51 | 1.13 | 0.78 |
| (二)稀释每股收益 | 0.42 | 1.47 | 1.12 | 0.77 |
| 八、其他综合收益 | -1,894,057.5 | 47,771,029.86 | 47,787,449.9 | 94,982.07 |
| 归属于母公司股东的其他综合收益 | -1,898,713.12 | 47,754,922.4 | 47,810,707.42 | 71,236.56 |
| 九、综合收益总额 | 60,953,288.76 | 251,102,938.06 | 200,265,076.43 | 105,448,200.59 |
| 归属于母公司股东的综合收益总额 | 60,843,076.89 | 250,461,773.43 | 199,544,836.59 | 104,989,090.6 |
| 归属于少数股东的综合收益总额 | 110,211.87 | 641,164.63 | 720,239.84 | 459,109.99 |
| 公告日期 | 2024-04-26 | 2024-04-16 | 2023-10-28 | 2023-08-08 |
| 审计意见(境内) | | 标准无保留意见 | | |